SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Acacia (ACRI)--a stock for the future

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Paul Lee who started this subject7/16/2002 7:10:40 AM
From: Paul Lee   of 1135
 
CombiMatrix Completes Milestone in Strategic Alliance with Roche
BUSINESS WIRE - July 16, 2002 05:59
NEWPORT BEACH, Calif., Jul 16, 2002 (BW HealthWire) -- Acacia Research Corporation (Nasdaq:ACRI) announced today that its majority owned subsidiary, CombiMatrix, has completed a milestone in its strategic alliance with Roche Applied Science.

CombiMatrix's strategic alliance with Roche includes a collaboration for the development and commercialization of CombiMatrix's DNA microarray technology, enabling flexible and fast custom manufacturing of microarrays by electrochemical oligonucleotide synthesis in-situ. Under the terms of the agreement, Roche will market the hybridization-reader instrument, flexible custom content microarrays, and pre-designed "catalogue" content microarrays in combination with its own matching labeling and hybridization reagents as well as bioinformatic tools.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext